8legs: Mass general brigham

Your Followed Topics

#1 out of 2

Mass General Brigham trial finds high-dose vitamin D3 did not reduce COVID-19 severity or hospital visits.
Researchers observed a possible signal that vitamin D could influence long COVID outcomes.
The VIVID Trial enrolled 1,747 adults with COVID-19 and 277 household contacts across the United States and Mongolia.
Adherence to the vitamin D regimen showed a potential link to fewer long COVID symptoms eight weeks after infection.
The Journal of Nutrition published the randomized trial results in 2026.
Study authors call for further research in larger populations to confirm long COVID effects.
Funding and disclosures note support from foundations and vitamin D suppliers.
The VIVID Trial used a regimen of 9,600 IU/day for two days, then 3,200 IU/day for four weeks.
Household contacts of COVID-19 patients were included to assess transmission impact.
The trial balanced groups with stratified randomization and statistical weighting.

Vote 0

#2 out of 20.00%

New AI tool analyzed hospital data to identify patients at risk of intimate partner violence (IPV).
The combined model used both structured data and written medical notes to detect risk.
The tool correctly identified IPV risk in 88 percent of cases.
Researchers say the system could flag abuse years before victims seek hospital help.
The project views the tool as decision-support, not a diagnosis or disclosure mandate.
Study published in the journal Nature and funded discussions on public health impact.
The system could be integrated with electronic medical records for real-time use.
IPV refers to abuse from current or former partners and can cause serious harm.
The study used records from nearly 850 women with IPV and over 5,200 controls.
Researchers emphasized the tool signals risk to aid, not replace clinician judgment.
The authors plan to inform hospitals about real-time IPV risk during care.

Vote 0

Unlimited Access

Personalized Feed

Full Experience

By continuing, you agree to the Privacy Policy.. You also agree to receive our newsletters, you can opt-out any time.

Create an account and enjoy content that interests you with your personalized feed

Unlimited Access

Personalized Feed

Full Experience

By continuing, you agree to the Privacy Policy.. You also agree to receive our newsletters, you can opt-out any time.